{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:28:45Z","timestamp":1777339725271,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pharep.2017.02.022","type":"journal-article","created":{"date-parts":[[2017,3,5]],"date-time":"2017-03-05T02:17:52Z","timestamp":1488680272000},"page":"885-893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats"],"prefix":"10.1007","volume":"69","author":[{"given":"Zofia","family":"Rog\u00f3\u017c","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrycja","family":"Pa\u0144czyszyn-Trzewik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Sowa-Ku\u0107ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"5","key":"10.1016\/j.pharep.2017.02.022_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/dneu.20758","article-title":"The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity","volume":"70","author":"Castr\u00e9n","year":"2010","journal-title":"Dev Neurobiol"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2017.02.022_bib0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jad.2011.06.041","article-title":"Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression","volume":"135","author":"Satomura","year":"2011","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.pharep.2017.02.022_bib0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.022_bib0020","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","article-title":"Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus","volume":"15","author":"Smith","year":"1995","journal-title":"J Neurosci"},{"issue":"5 (Suppl. 1)","key":"10.1016\/j.pharep.2017.02.022_bib0025","first-page":"20","article-title":"Glucocorticoids, depression, and mood disorders: structural remodeling in the brain","volume":"54","author":"McEven","year":"2005","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.022_bib0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/ajp.157.1.115","article-title":"Hippocampal volume reduction in major depression","volume":"157","author":"Bremner","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.022_bib0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2004.02.033","article-title":"Depression: a case of neuronal life and death","volume":"56","author":"Duman","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.022_bib0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal BDNF immunoreactivity in subject treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.022_bib0045","first-page":"1393","article-title":"Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram, treatment","volume":"10","author":"Lee","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.022_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0091-3057(96)00169-4","article-title":"Antidepressant-like effect of brain\u2013derived neurotrophic factor (BDNF)","volume":"56","author":"Siuciak","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.pharep.2017.02.022_bib0055","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produced antidepressant effects in behavioural models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J Neurosci"},{"issue":"29","key":"10.1016\/j.pharep.2017.02.022_bib0060","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.0402141101","article-title":"Essential role of brain-derived neurotrophic factor in adult hippocampal function","volume":"101","author":"Monteggia","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.pharep.2017.02.022_bib0065","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J Neurosci"},{"issue":"1-2","key":"10.1016\/j.pharep.2017.02.022_bib0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2004.07.065","article-title":"The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels","volume":"1024","author":"Jacobsen","year":"2004","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.022_bib0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004714-199802000-00018","article-title":"Additing risperidone to selective serotonin reuptake inhibitor improves chronic depression","volume":"18","author":"O\u2019Connor","year":"1998","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.022_bib0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4088\/JCP.v60n0410","article-title":"Risperidone augmentation of selective serotonin reuptake inhibitors in major depression","volume":"60","author":"Ostroff","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.pharep.2017.02.022_bib0085","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4088\/JCP.v63n0812","article-title":"An open pilot study combining risperidone and selective serotonin reuptake inhibitor as initial antidepressant therapy","volume":"63","author":"Hirose","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.pharep.2017.02.022_bib0090","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301113","article-title":"Effects of risperidone augmentation in patients with treatment-resistant depression: results of open-label treatment followed by double-blind continuation","volume":"31","author":"Rapaport","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.022_bib0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpsychires.2008.05.003","article-title":"A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression","volume":"43","author":"Keitner","year":"2009","journal-title":"J Psychiatry Res"},{"key":"10.1016\/j.pharep.2017.02.022_bib0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-2999(02)02957-6","article-title":"Comparative behavioral effects of typical and atypical antipsychotic drugs in rhesus monkey","volume":"462","author":"Kumar","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2017.02.022_bib0105","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1021\/jm049632c","article-title":"Discovery of new tetracycline tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents","volume":"48","author":"Fern\u00e1ndez","year":"2005","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.pharep.2017.02.022_bib0110","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S1734-1140(12)70936-2","article-title":"Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test","volume":"64","author":"Rog\u00f3\u017c","year":"2012","journal-title":"Pharmacol Rep"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.022_bib0115","first-page":"471","article-title":"The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats","volume":"67","author":"Kami\u0144ska","year":"2016","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"10.1016\/j.pharep.2017.02.022_bib0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"Mirtazapine: a review of its use in major depression and other psychiatric disorders","volume":"23","author":"Croom","year":"2009","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.pharep.2017.02.022_bib0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-014-3671-6","article-title":"Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA\/BDNF pathway","volume":"232","author":"Pochwat","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.pharep.2017.02.022_bib0130","first-page":"817","article-title":"Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats","volume":"60","author":"Rog\u00f3\u017c","year":"2008","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.022_bib0135","first-page":"661","article-title":"Repeated treatment with mirtazapine induces brain-derived neurotrophic factor gene expression in rats","volume":"56","author":"Rog\u00f3\u017c","year":"2005","journal-title":"J Physiol Pharmacol"},{"issue":"7","key":"10.1016\/j.pharep.2017.02.022_bib0140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0006-3223(03)00073-8","article-title":"Effect of electroconvulsive seizures and antidepressant drugs on the brain-derived neurotroppic factor protein in rat brain","volume":"54","author":"Altar","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.pharep.2017.02.022_bib0145","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1523\/JNEUROSCI.22-08-03262.2002","article-title":"cAMP response element-binding protein is essentials for the up-regulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs","volume":"22","author":"Conti","year":"2002","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.pharep.2017.02.022_bib0150","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1523\/JNEUROSCI.20-11-04030.2000","article-title":"cAMP response element-mediated gene transcriptionis upregulated by chronic antidepressant treatment","volume":"20","author":"Thome","year":"2000","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.pharep.2017.02.022_bib0155","first-page":"1831","article-title":"Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascade","volume":"29","author":"Tiraboschi","year":"2004","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.022_bib0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependentmechanism","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"issue":"2-3","key":"10.1016\/j.pharep.2017.02.022_bib0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2010.06.028","article-title":"Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats","volume":"643","author":"Alboni","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.022_bib0170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0306-4522(92)90292-A","article-title":"Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system","volume":"51","author":"Merlio","year":"1992","journal-title":"Neuroscience"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401630398X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401630398X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:00Z","timestamp":1752611820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.02.022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S173411401630398X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.02.022","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}